Drug Trial Radar · NCT01298700
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Last checked: Nov 19, 2026Latest source record: Sep 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
806
Actual
Start
May 31, 2011
Primary completion
Dec 6, 2016
Study completion Dec 6, 2016
Sponsor
- Lead sponsor
- AllerganAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Feb 18, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the long-term safety of bimatoprost 0.01% ophthalmic solution compared with bimatoprost 0.03% ophthalmic solution in patients with glaucoma or ocular hypertension.
Conditions
- Glaucoma
- Ocular Hypertension
Interventions
bimatoprost 0.01% ophthalmic solutionDrug
One drop of bimatoprost 0.01% ophthalmic solution instilled to each eye, once daily in the evening for 2 years.
bimatoprost 0.03% ophthalmic solutionDrug
One drop of bimatoprost 0.03% ophthalmic solution instilled to each eye, once daily in the evening for 2 years.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Reporting One or More Treatment-Related Ocular Surface Adverse EventsTime frame: 24 Months
Locations
50 sites in 10 countries. Site status is shown where the registry gives one.
UZ Leuven
Leuven, Belgium
CHU Sart Tilman
Liège, Belgium
University Hospital Brno
Brno, Czechia
Eye Clinic
Frýdštejn, Czechia
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, France
Clinique Montcelli
Marseille, France
Universitat Augenklinik
Freiburg im Breisgau, Germany
Univ. des Saarlandes
Homburg Saar, Germany
Johannes Gutenberg Univ Mainz
Mainz, Germany
Thelen Private Practice
Műnster, Germany
Augenzentrum Siegburg
Siegburg, Germany
Department of Ophthalmology, University of Tuebingen
Tübingen, Germany
Budapest Retina Associates Kft.
Budapest, Hungary
University Med. School of Debrecen
Debrecen, Hungary
Josa Andras Oktatokorhaz
Nyíregyháza, Hungary
University of Szeged Szent-Gyorgyi Albert Clinical Center
Szeged, Hungary
Carmel Medical Center
Haifa, Israel
Glaucoma Service The Rabin Medical Center
Petach Tiqva, Israel
Kaplan Medical Center
Rehovot, Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Sheba Medical Center
Tel HaShomer, Israel
Azienda Ospedaliera Universitaria
Catania, Italy
Azlenda Ospedaliero Universitaria Careggi Viale
Florence, Italy
Istituto Scientifico San Raffaele
Milan, Italy
Dipartimento di Scienze Otorino-Odonto-Oftalmologiche e Cerv
Parma, Italy
Fondazione G.B. Bietti per l'Oftalmologia I.R.C.C.S.
Rome, Italy
EuroMedic Kliniki Specjalistyczne
Katowice, Poland
ZOZ OKO- TEST Poradnia Okulistyczna
Nowy Targ, Poland
Szpital Kliniczny Przemienienia Panskiego Uniwersytetu
Poznan, Poland
Samodzielny Publiczny Szpital
Szczecin, Poland
Osrodek Badan Klinicznych Euromedis Sp. z o.o.
Szczecin, Poland
Samodzielny Szpital Kliniczny
Warsaw, Poland
Akad. Med. w Warszawie - Ketedra I Klin. Okulistki Wyzialu L
Warsaw, Poland
Centro de Ojos de La Coruña
A Coruña, Spain
Hospital de Torrevieja
Alicante, Spain
Instituro Condal de Oftalmologia
Barcelona, Spain
Hospital Quiron Barcelona
Barcelona, Spain
Valles Oftalmologia Recerca
Barcelona, Spain
Hospital Ramon y Cajal
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.